Incretins: based therapy for type-2 Diabetes mellitus (T2DM)

Abstract

The treatment of type 2 diabetes mellitus is metformin and sulfonylurea (SU) as first-line anti- diabetic therapies for many years. It is the first line treatment though the combination results in a progressive decline in [beta]-cell function. There is 50% decline in [beta] cell by 3 years in diabetic patients so there is requirement of an additional pharmacological agent to maintain the glycosylated hemoglobin (HbA1c) <7.0% (UKPDS). Gliptins represent a novel class of agents that improve beta cell health and suppress glucagon, resulting in improved post-prandial and fasting hyperglycemia. They function by augmenting the incretin system (GLP-1 and GIP) preventing their metabolism by dipeptidyl peptidase-4 (DPP-4). They are not only efficacious but also safe as they do not cause significant hypoglycemia, and are weight neutral.

Authors and Affiliations

Sinha Ritesh kumar*, Alam Md Shadab, Kumar Pawan, Chandra Satish

Keywords

Related Articles

Development and evaluation of buccal film of norethindrone for birth-control

Norethindrone is the class of progesterone which is used to prevent pregnancy. The plasma levels were considerably higher in women than men, especially at low dose levels. The plasma half –life of norethindrone is a...

Novel Study in Sustained Release Drug Delivery System: A Review

Among all drug delivery system, oral drug delivery is the most preferred route for administration of various drugs. Sustained release products provide advantage over conventional dosage form by optimizing bio pharmaceu...

Neonatal sepsis in a General SudaneseTeaching Hospital, Sudan

Background:The objectves of the study were to determine the causes, clinical presentation, management and outcome of neonatal sepsis in Gadarif Teaching Hospital, Sudan. Methods:The study was descriptive conducted in t...

Technology transfer in Pharmaceutical Industry: A review

The term technology transfer refers to the process of movement of technology from one unit to another. The transfer may be said to be successful if the receiving unit and the transferee can effectively utilize the tech...

Selfie Elbow-Latest Tech Injury

Selfie taking is emerging as an avid sport in which everyone can participate and share selfportraits with the world. And like any other sport, it too has its share of injuries. Although it is too early to comment on the...

Download PDF file
  • EP ID EP31465
  • DOI -
  • Views 335
  • Downloads 1

How To Cite

Sinha Ritesh kumar*, Alam Md Shadab, Kumar Pawan, Chandra Satish (2014). Incretins: based therapy for type-2 Diabetes mellitus (T2DM). International Journal of Pharmaceutical and Medicinal Reserach, 2(2), -. https://europub.co.uk/articles/-A-31465